1887

Abstract

SUMMARY

In a series of experiments performed in hamsters and mice, administration of mixtures of detergent-disrupted (SV) influenza A X49 (H3N2) virus and inactivated X49 whole virus (WV) vaccine induced lower serum antibody titres than equivalent or lower doses of WV vaccine alone. This reduction in antibody titre was also observed using influenza A (H1N1) and influenza B (B/Hong Kong/8/73) SV and WV vaccine preparations. The results suggested that SV preparations can suppress the serum antibody response to WV vaccine. A suppressive effect of SV influenza virus on WV vaccine was also observed in an antibody-forming system, using primed mouse spleen cells. In this system, SV induced markedly lower IgG and IgM antibody responses than WV vaccine, and mixtures of SV with WV reproducibly resulted in lowered antibody responses compared to those elicited by WV alone. Possible reasons for these findings are discussed in the light of the known low immunogenicity observed for split and subunit influenza virus vaccine preparations in animals and in unprimed human populations.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-2-441
1987-02-01
2022-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/2/JV0680020441.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-2-441&mimeType=html&fmt=ahah

References

  1. Adorini L., Harvey M. A., Miller A., Sercarz E. E. 1979; Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. Journal of Experimental Medicine 150:293–306
    [Google Scholar]
  2. Anders E. M., Peppard P. M., Burns W. H., White D. O. 1979; In vitro antibody response to influenza virus. I. T- cell dependence of secondary response to hemagglutinin. Journal of Immunology 123:1356–1361
    [Google Scholar]
  3. Anders E. M., Katz J. M., Brown L. E., Jackson D. C., White D. O. 1981; The specificity of T cells for influenza virus hemagglutinin. In Genetic Variation among Influenza Viruses pp 547–565 Nayak D. P. Edited by London: Academic Press;
    [Google Scholar]
  4. Audibert F., Chedid L., Hannoun C. 1977; Augmentation de la response immunitaire au vaccin grippal parun glycopeptide synthetique adjuvant (N-acetyl-muramyl-l-alanyl-d-isoglutamine). Comptes rendus hebdoma- daires des seances de l’Academie des Sciences 285:467–470
    [Google Scholar]
  5. Barry D. W., Staton E., Maynor R. E. 1974; Inactivated influenza vaccine efficacy. Diminished antigenicity of split-product vaccines in mice. Infection and Immunity 10:1329–1336
    [Google Scholar]
  6. Casali p., Patrick-SISSONS J. G., Buchmeier M. J., Oldstone M. B. A. 1981; In vitro generation of human cytotoxic lymphocytes by virus: viral glycoproteins induce non-specific cell-mediated cytotoxicity without release of interferon. Journal of Experimental Medicine 154:840–855
    [Google Scholar]
  7. Crawford C. R., Jennings R., Bradford N., Potter C. W. 1982; The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines. Clinical and Experimental Immunology 48:739–746
    [Google Scholar]
  8. Crawford C. R., Mukhlis F., Jennings R., Oxford J. S., Hockley D. J., Potter C. W. 1984; Use of a zwitterionic detergent for the preparation of an influenza virus vaccine. I. Preparation and characterisation of disrupted virions. Vaccine 2:193–198
    [Google Scholar]
  9. Davenport F. M. 1968; Antigenic enhancement of ether-extracted influenza virus vaccine by A1PO4 . Proceedings of the Society for Experimental Biology and Medicine 127:587–590
    [Google Scholar]
  10. Eastwood L. M., Jennings R., Milner R. D. G., Potter C. W. 1979; Reactogenicity and immunogenicity of a surface-antigen adsorbed influenza virus vaccine in children. Journal of Clinical Pathology 32:534–537
    [Google Scholar]
  11. Ennis F. A., Meager A. 1981; Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. Journal of Experimental Medicine 154:1279–1289
    [Google Scholar]
  12. Gross P. A., Ennis F. A., Noble G. R., Gaerlan P. F., Davis W. J., Denning C. E. 1980; Influenza vaccine in children: improved immunogenicity with few reactions following one high dose of split-product vaccine. Journal of Pediatrics 97:56–60
    [Google Scholar]
  13. Hackett C. J., Taylor P. M., Askonas B. A. 1983; Stimulation of cytotoxic T cells by liposomes containing influenza virus or its components. Immunology 49:255–263
    [Google Scholar]
  14. Jennings R., Potter C. W., Mcclaren C., Brady M. i. 1975; A new, surface-antigen adsorbed influenza virus vaccine I. Studies on immunogenicity in hamsters. Journal of Hygiene 75:341–352
    [Google Scholar]
  15. Jennings R., Potter C. W., Massey P. M. O., Duerden B. I., Martin J., Bevan A. M. 1981a; Reactions and serological responses of volunteers to one and two doses of inactivated influenza virus vaccines. Journal of Hygiene 86:1–16
    [Google Scholar]
  16. Jennings R., Smith T. L., Potter C. W. 1981b; Useofthe enzyme-linked immunosorbent-assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study. Medical Microbiology and Immunology 162:247–258
    [Google Scholar]
  17. Jennings R., Smith T. L., Spencer R. C., Mellersh A. R., Edey D., Fenton P., Potter C. W. 1984; Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. Vaccine 2:75–80
    [Google Scholar]
  18. Laver W. G., Webster R. G. 1976; Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine. Virology 69:511–522
    [Google Scholar]
  19. Mukhlis F. A., Crawford C. R., Jennings R., Potter C. W. 1984; Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 2. Immunogenicity of Empigen-treated virus in animals. Vaccine 2:199–203
    [Google Scholar]
  20. Potter C. W., Jennings R., Mcclaren C., Edey D., Stuart-HARRIS C. H. 1975; A new surface antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. Journal of Hygiene 75:353–362
    [Google Scholar]
  21. Rock K. L., Benaceraf B. 1983; Inhibition of antigen-specific T-lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation. Journal of Experimental Medicine 157:1618–1634
    [Google Scholar]
  22. Scher M. G., Beller D. I., Unanue E. R. 1980; Demonstration of a soluble mediator that induces exudates rich in la-positive macrophages. Journal of Experimental Medicine 152:1684–1698
    [Google Scholar]
  23. Schwartz M., Waltenbaugh C., Dorf M., Cesla R., Sela M. 1976; Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses. Proceedings of the National Academy of Sciences, U.S.A 73:2862–2866
    [Google Scholar]
  24. Steeg P. S., Johnson H. M., Oppenheim J. J. 1982; Regulation of murine macrophage la expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. Journal of Immunology 129:2402–2406
    [Google Scholar]
  25. Tai-Kim Y., Merrifield N., Zarchy T., Brody N. I., Siskind G. W. 1974; Studies on antigenic competition. III. Effect of antigenic competition on antibody affinity. Immunology 26:943–955
    [Google Scholar]
  26. Taussig M. J. 1974; The effect of Freund’s complete adjuvant on the specificity of an immune response, and its relationship to antigenic competition. Cellular Immunology 11:484–487
    [Google Scholar]
  27. Taussig M. J. 1977; Antigenic competition. In The Antigens 4: pp 333–368 Sela M. Edited by New York & London: Academic Press;
    [Google Scholar]
  28. Thibodeau L., Naud p., Boudreault A. 1981; An influenza immunosome: its structure and antigenic properties. A model for a new type of vaccine. In Genetic Variation among Influenza Viruses p 587: Nayak D. P. Edited by London: Academic Press;
    [Google Scholar]
  29. Turkin D., Sercarz E. E. 1977; Key antigenic determinants in regulation of the immune response. Proceedings of the National Academy of Sciences, U.S.A 74:3984–3987
    [Google Scholar]
  30. Unanue E. R., Beller D. I., Lu c. Y., Allen P. M. 1984; Antigen presentation: comments on its regulation and mechanism. Journal of Immunology 132:1–5
    [Google Scholar]
  31. Webster R. G., Glezen W. P., Hannoun C., Laver W. G. 1977; Potentiation of the immune response to influenza virus subunit vaccines. Journal of Immunology 119:2073–2077
    [Google Scholar]
  32. Wood I. M., Schild G. C., Newman R. W., Seagroatt V. 1977; Application of an improved single radial immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. Developments in Biological Standardization 39:193–200
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-2-441
Loading
/content/journal/jgv/10.1099/0022-1317-68-2-441
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error